Publications by authors named "Mary Anne Fallon"

Claim this Profile
M
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
Matthew R Smith, Hang Lee, Francis McGovern, Mary Anne Fallon, Melissa Goode

Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.
Matthew R Smith, Hang Lee, Mary Anne Fallon, David M Nathan

Urology· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
M Dror Michaelson, Donald S Kaufman, Hang Lee, Francis J McGovern, Philip W Kantoff, Mary Anne Fallon

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.
Matthew R Smith, Mary Anne Fallon, Hang Lee, Joel S Finkelstein

J Clin Endocrinol Metab· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.
Matthew R Smith, Mary Anne Fallon, Melissa J Goode

Urology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of body fat by dual-energy X-ray absorptiometry and bioimpedance analysis in men with prostate cancer.
Matthew R Smith, Vanessa Fuchs, Ellen J Anderson, Mary Anne Fallon, Judith Manola

Nutrition· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in body composition during androgen deprivation therapy for prostate cancer.
Matthew R Smith, Joel S Finkelstein, Francis J McGovern, Anthony L Zietman, Mary Anne Fallon

J Clin Endocrinol Metab· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis